Join CBSET at RESI Boston, September 21-23, 2022, at the Westin Copley Place in Boston, MA.
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development.
This event will include both in-person (September 21-22) and virtual (September 23) options. In-person attendees can expect two days of active partnering, interactive panels, educational workshops, and live pitch sessions. Virtual attendees can still benefit from access to content recordings, as well as a single day dedicated exclusively to digital partnering.
CBSET will be exhibiting on 9/21 and 22, and will be participating in the virtual partnering on 9/23. Please contact us to meet up, in person or virtually, at the RESI Boston conference.
Related CBSET Services:
Related CBSET research:
"Morphometric analysis of the human common hepatic artery (CHA) reveals a rich and accessible target for sympathetic liver denervation." Abraham Rami Tzafriri PhD, Fernando Garcia-Polite PhD, John Keating DVM DACVP, Raffaele Melidone DVM DACVP, Jennifer Knutson BS, Peter Markham MS, Elazer R. Edelman MD PhD, Felix Mahfoud MD. Scientific Reports, 10.1038/s41598-022-05475-6.
"Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension." Tzafriri AR, Keating JH, Markham PM, Spognardi AM, L Stanley JR, Wong G, Zani BG, Highsmith D, O'Fallon P, Fuimaono K, Mahfoud F, Edelman ER. Sci Transl Med. 2015 Apr 29;7(285):285ra65. doi: 10.1126/scitranslmed.aaa3236.
"Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings." by Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release, March 28, 2018, Volume 274, Pages 102-108.
"Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come." Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion on Drug Delivery, Volume 15, Issue 4, March 9, 2018, Pages 319-324.
"A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma." Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials, Volume 93, July 2016, Pages 71-82.
"Percutaneous Hepatic Perfusion With Filtered Melphalan for Localized Treatment of Metastatic Hepatic Disease: A Risk Assessment." Pauline E McEwan, Lynn Bailey, David Trost, Christopher Scull, John H Keating, Misty Williams, Robert J Guttendorf. Int J Toxicol. Nov/Dec 2018;37(6):434-447. doi: 10.1177/1091581818811306.
"Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheter." Tsukada H, Entcheva-Dimitrov P, Ernst A, Rafeq S, Keating JH, Seward KP, Yarmus L. Respirology. 2018 Apr;23(4):399-405. doi: 10.1111/resp.13214.